Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sham-Controlled Rapid-Acting Neuromodulation for Depression

NCT07487454 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.

NCT NCT07487454
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07487454 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sham-Controlled Rapid-Acting Neuromodulation for Depression
Lead sponsor
University of California, Davis
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 31, 2026
Completion date
May 31, 2028
Enrollment
264 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression - major depressive disorder